1.
Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
Stoner Ari, Harris Alon, Oddone Francesco, Belamkar Aditya, Verticchio Vercellin Alice Chandra, Shin Joshua et al.
Br J OphthalmolAug 202136 citationsReview
This review examined topical CAIs for glaucoma, finding they remain valuable combination therapy, potentially influencing ocular hemodynamics beyond pressure reduction, despite less frequent primary use.